super p force
| Product dosage: 160mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $3.21 | $96.40 (0%) | 🛒 Add to cart |
| 60 | $2.95 | $192.81 $176.74 (8%) | 🛒 Add to cart |
| 90 | $2.86 | $289.21 $257.08 (11%) | 🛒 Add to cart |
| 120 | $2.81 | $385.61 $337.41 (13%) | 🛒 Add to cart |
| 180 | $2.76
Best per pill | $578.42 $497.08 (14%) | 🛒 Add to cart |
Similar products
Let me walk you through what we’ve observed with Super P Force in clinical practice - this isn’t the polished marketing material, but the real-world experience that actually matters when you’re considering this combination therapy for patients.
Super P Force represents one of those interesting combination approaches that emerged from observing what clinicians were already doing in practice - prescribing sildenafil citrate and dapoxetine together for men presenting with both erectile dysfunction and premature ejaculation. The pharmaceutical development essentially formalized what was already happening off-label. I remember when these combination products first hit the market around 2012-2013, there was considerable debate among our urology department about whether we should embrace the convenience or stick with separate prescriptions for better dosing flexibility.
Key Components and Bioavailability of Super P Force
The formulation contains two active pharmaceutical ingredients with distinct mechanisms and pharmacokinetics:
Sildenafil Citrate (100mg)
- Phosphodiesterase type 5 (PDE5) inhibitor
- Onset: Typically 30-60 minutes
- Duration: 4-6 hours
- Bioavailability: ~40% (extensive first-pass metabolism)
- Food interaction: High-fat meals delay Tmax by approximately 60 minutes
Dapoxetine (60mg)
- Selective serotonin reuptake inhibitor (SSRI)
- Rapid absorption (Tmax: 1-2 hours)
- Short half-life (approximately 1.5 hours)
- Designed specifically for on-demand use rather than chronic dosing
What’s clinically interesting is how these two components interact practically. The sildenafil component requires planning - patients need to understand the timing relative to sexual activity and meal consumption. The dapoxetine, being faster-acting, fits better with spontaneous use, but this creates an inherent tension in the combination product that requires careful patient education.
Mechanism of Action: Scientific Substantiation
The dual mechanism approach targets two distinct but often comorbid conditions:
For erectile dysfunction: Sildenafil inhibits PDE5 in the corpus cavernosum, preventing breakdown of cyclic guanosine monophosphate (cGMP). This enhances nitric oxide-mediated vasodilation in response to sexual stimulation. The thing many patients don’t understand is that it doesn’t create erection spontaneously - it requires stimulation. I’ve had to explain this to probably two dozen patients who expected otherwise.
For premature ejaculation: Dapoxetine increases synaptic serotonin levels, which appears to modulate the ejaculatory reflex threshold through 5-HT2C and 5-HT1A receptors. The rapid onset and short duration are specifically engineered for this indication - unlike conventional SSRIs which require weeks of continuous dosing.
What’s fascinating clinically is how these mechanisms sometimes interact unexpectedly. I’ve seen cases where the confidence improvement from better erectile function actually reduces performance anxiety, which then independently helps with ejaculatory control - creating a positive feedback loop that’s difficult to quantify in clinical trials but very real in practice.
Indications for Use: What is Super P Force Effective For?
Super P Force for Erectile Dysfunction with Premature Ejaculation
This is the primary indication - men with both conditions simultaneously. The prevalence of this comorbidity is higher than many clinicians realize - studies suggest 30-50% of men with ED also experience PE. The convenience of a single tablet addresses what we call “treatment burden” - something that significantly impacts adherence.
Super P Force for Treatment-Resistant Premature Ejaculation
We’ve occasionally used this off-label in men with severe PE who haven’t responded adequately to dapoxetine alone. The theory - which seems borne out in limited clinical experience - is that improved erectile confidence might help break the anxiety-performance cycle that often perpetuates PE.
Super P Force for Psychological Sexual Disorders
In cases where there’s significant psychological component to sexual dysfunction, the rapid efficacy can sometimes help break negative patterns. However, this should always be combined with proper psychological support - medication alone rarely resolves deep-seated psychological issues.
Instructions for Use: Dosage and Course of Administration
The dosing requires careful individualization:
| Indication | Sildenafil Component | Dapoxetine Component | Frequency | Administration |
|---|---|---|---|---|
| ED with PE | 100mg | 60mg | Maximum once daily | 1-3 hours before activity, empty stomach preferred |
| Mild cases | 50mg (half tablet) | 30mg (half tablet) | As needed | Adjust based on tolerance |
| Elderly patients | 25mg starting dose | 30mg starting dose | Conservative dosing | Monitor for orthostasis |
What I emphasize to patients: Start low, go slow. The 100mg/60mg combination is quite potent, and many patients do better starting with half tablets. I learned this the hard way early on when I had a 68-year-old gentleman who took the full dose and experienced significant dizziness and nausea - he didn’t return for follow-up, which taught me the importance of more conservative initial dosing.
Contraindications and Drug Interactions
Absolute contraindications:
- Concomitant nitrate therapy (can cause profound hypotension)
- Severe hepatic impairment
- Significant cardiovascular disease (recent MI, unstable angina)
- History of stroke or TIA
Significant drug interactions:
- Alpha-blockers: Additive hypotension
- Strong CYP3A4 inhibitors (ketoconazole, ritonavir): Increased levels of both components
- Other PDE5 inhibitors: Absolutely contraindicated
- MAO inhibitors: Serotonin syndrome risk with dapoxetine
The interaction profile is more complex than with either component alone, requiring thorough medication review. I nearly missed a significant interaction in a 54-year-old patient who was on fluoxetine chronically - adding dapoxetine created serotonin-related side effects that were quite unpleasant for him. This taught me to be extra vigilant about screening for other serotonergic agents.
Clinical Studies and Evidence Base
The evidence for the individual components is robust, but combination studies are more limited:
Sildenafil evidence:
- Over 130 clinical trials involving 14,000+ patients
- IIEF scores improve by 4-8 points versus placebo
- 70-80% of patients report improved erections
Dapoxetine evidence:
- PE-specific clinical trial program involving 6,000+ men
- Intravaginal ejaculatory latency time (IELT) increases 3-4 fold
- 2.5-3.0 point improvement in PEP scores
Combination challenges: The clinical trials for the combination product showed efficacy, but what’s interesting is that the real-world effectiveness seems somewhat higher than the trial data would suggest. My theory is that the trial setting doesn’t capture the convenience benefit and the psychological impact of addressing both issues simultaneously.
Comparing Super P Force with Similar Products and Choosing Quality
When comparing to separate prescriptions:
- Advantage: Convenience, potentially improved adherence
- Disadvantage: Less dosing flexibility, fixed ratio
Versus other combination products:
- Different sildenafil/dapoxetine ratios may suit different patients
- Generic versions vary in quality - stick with reputable manufacturers
The quality issue is real - I’ve seen patients respond differently to different generic versions, likely due to variations in excipients affecting bioavailability. This isn’t well-studied but is clinically observable.
Frequently Asked Questions about Super P Force
What is the recommended course of Super P Force to achieve results?
Most patients see immediate improvement, but optimal results often develop over 4-8 uses as confidence builds and they learn to time administration properly.
Can Super P Force be combined with alcohol?
Limited alcohol (1-2 drinks) is usually acceptable, but excessive alcohol increases side effect risk and can counter the therapeutic benefits.
Is Super P Force safe long-term?
The safety profile appears similar to the individual components used long-term, but periodic re-evaluation is recommended to assess continued need.
Can Super P Force be used for performance enhancement in men without dysfunction?
Absolutely not - this is medication for diagnosed conditions, not enhancement for healthy individuals.
Conclusion: Validity of Super P Force Use in Clinical Practice
The risk-benefit profile favors Super P Force for appropriate patients - men with genuine comorbid ED and PE who understand the proper use and limitations. The convenience factor significantly impacts real-world adherence, which often outweighs the theoretical advantages of separate prescriptions.
I remember particularly well a patient named Michael, 42-year-old accountant, who’d been struggling with both issues for years. He’d tried various treatments separately with limited success - the complexity of managing two medications with different timing requirements was overwhelming for him. When we started Super P Force, the first attempt wasn’t perfect - he took it after a heavy dinner and the onset was delayed. But by the third use, he’d figured out the timing and the improvement was dramatic. At 6-month follow-up, he told me it had literally saved his marriage - his wife accompanied him to the appointment and confirmed the transformation in their relationship.
What surprised me was that after about 8 months, he found he needed the medication less frequently - the success experiences had rebuilt his confidence to the point where he could often perform adequately without pharmaceutical support. This pattern of “confidence building leading to reduced medication need” I’ve now seen in probably a dozen patients, though it’s not something you’ll find in the clinical trial literature.
The development team initially disagreed about the fixed-dose combination - some argued for multiple strength options, but market research suggested simplicity would improve adherence. They were probably right from a commercial perspective, though clinically I still wish we had more flexibility in dosing ratios.
Long-term follow-up with these patients has been revealing - about 30% eventually transition to occasional use rather than regular dependence, which is a better outcome than I initially expected. The key is proper patient selection and education - this isn’t a medication for casual use, but for properly diagnosed patients, it can be genuinely transformative.